However, the absence of solid human clinical trial data means these therapies should be approached with scientific caution and humility
Not intended for use in humans or animals
The global burden of disease attributable to high body mass index in 195 countries and territories, 19902017: an analysis of the Global Burden of Disease Study
BPC-157 demonstrates neuroprotective effects across traumatic brain injury, stroke, spinal cord injury, and peripheral nerve damage in animal models
The KLOW program may include BPC-157, TB-500, KPV and GHK-Cu
When done correctly, reconstituted peptides maintain potency for weeks under proper storage, enabling long-term studies without constant re-preparation